Agenus (AGEN) Appoints Robert B. Stein, MD, Phd, As Chief Scientific Officer
1/13/2014 10:58:46 AM
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, today announced the appointment of Robert B. Stein, M.D., Ph.D., to the newly-created position of Chief Scientific Officer (CSO).
Help employers find you! Check out all the jobs and post your resume.
comments powered by